NUWE Key Statistics, Chart & Performance
The current stock price of NUWE is 2.61 USD. In the past month the price increased by 32.49%. In the past year, price decreased by -95.11%.
NUWE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to NUWE. When comparing the yearly performance of all stocks, NUWE is a bad performer in the overall market: 94.89% of all stocks are doing better.
NUWE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NUWE. NUWE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NUWE Financial Highlights
Over the last trailing twelve months NUWE reported a non-GAAP Earnings per Share(EPS) of -1630.02. The EPS increased by 91.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -207.46% | ||
| ROE | -423.19% | ||
| Debt/Equity | 0 |
NUWE Forecast & Estimates
For the next year, analysts expect an EPS growth of 98.39% and a revenue growth -8.15% for NUWE
NUWE Ownership
NUWE Latest News, Press Relases and Analysis
NUWE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.33 | 189.676B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.14 | 168.855B | ||
| SYK | STRYKER CORP | 23.7 | 138.597B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 115.097B | ||
| BDX | BECTON DICKINSON AND CO | 13.98 | 58.942B | ||
| IDXX | IDEXX LABORATORIES INC | 43.51 | 51.391B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.59 | 45.321B | ||
| RMD | RESMED INC | 22.12 | 38.981B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.06 | 37.494B | ||
| DXCM | DEXCOM INC | 27.8 | 27.258B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NUWE
Company Profile
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Company Info
NUWELLIS INC
12988 Valley View Rd
Eden Prairie MINNESOTA 55344 US
CEO: Nestor Jaramillo
Employees: 38
Phone: 19523454200
NUWELLIS INC / NUWE FAQ
Can you describe the business of NUWELLIS INC?
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Can you provide the latest stock price for NUWELLIS INC?
The current stock price of NUWE is 2.61 USD. The price increased by 5.67% in the last trading session.
Does NUWE stock pay dividends?
NUWE does not pay a dividend.
What is the ChartMill rating of NUWELLIS INC stock?
NUWE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the employee count for NUWE stock?
NUWELLIS INC (NUWE) currently has 38 employees.
What is the outstanding short interest for NUWELLIS INC?
The outstanding short interest for NUWELLIS INC (NUWE) is 0.3% of its float.